Background: Few studies have demonstrated the association of smoking, as an independent risk factor, with postoperative cardiac events.
Introduction
According to the Brazilian Public Health System (Data-SUS-2007) 1 , 3 ,210,593 surgical hospitalizations have occurred in Brazil. The rate of Brazilian perioperative mortality is between 2% and 2.6% 2, 3 , which is considered high, when compared with those in the United States (0.5%) 4 and Europe (0.3%) 5 .
Smoking is associated with postoperative pulmonary complications [6] [7] [8] . Among the most important association are increased mechanical ventilation time, pneumonia 9 , infection and difficulty in wound healing 10 . Other complications have been previously described as cardiovascular [11] [12] [13] , immunological dysfucntion 12 and alteration in the metabolism of certain drugs In this sample, the study groups were stratified by the smoking status as: current smokers (patients that smoked daily up to 60 days before the preoperative assessment); ex-smokers (patients who stopped smoking for more than 8 weeks before the preoperative assessment); AP smokers (smokers and exsmokers) and nonsmokers (patients that never smoked) 8 .
The preoperative variables analyzed included age, sex, coronary disease 17 (AMI > 6 months, AMI < 6 months, presence of pathological Q wave, angina or myocardial revascularization), heart failure, history of cerebrovascular accident 18 , diabetes mellitus 19 , systemic arterial hypertension (SAH) 20 , surgery due to neoplasia, history of hepatopathy (clinical signs and/or laboratory alterations) and chronic pulmonary disease 21 .
The laboratory variable 22, 23 (PaO 2 < 60 mmHg; PaCO 2 > 50 mmHg; serum potassium < 3 mEq/l; serum creatinine > 2.0 mg/dl; serum urea > 50 mg/dl; transaminases > 2x the reference value) was defined as present when one or more of these alterations were found or when their presence was suspected due to signs and symptoms and verified through complementary exams. A specialist analyzed the electrocardiogram; however, the left ventricular overload was defined through Sokolov criteria. The American Society of Anesthesiology's Physical Status Classification 24 (ASA PS) and the Cardiac Risk Index of the American College of Physicians (ACP) 25 were used. The operations were classified as elective or emergency surgeries and, according to their category, as low, intermediate or high risk 26 .
The studied postoperative cardiac events were myocardial infacrtion 25, 27 , unstable angina 28 , pulmonary edema and arrhythmias with hemodynamic instability. The latter was defined by the presence of ventricular tachycardia or fibrillation or supraventricular tachycardia associated to dyspnea, systolic arterial pressure < 90 mmHg or angina. Pulmonary edema was defined by dyspnea, crackling rales and pulmonary congestion at the plain chest x-ray, associated with fast clinical improvement after diuretic therapy. These events were analyzed in combination.
Other analyzed events were cardiac death (necropsy data) and general mortality in up to 30 days after the surgery (combination of intrahospital mortality and mortality in up to 30 days). The mortality data after hospital discharge was obtained from the patients' files or through telephone contact with family members.
The data were analyzed using the statistical package SPSS for Windows, release 15.0 and Epiinfo, release 6.0. We used the Chi-square test to analyze associations between the studied groups and a logistic regression model (stepwise) to evaluate the role of smoking as an independent variable for perioperative cardiac events. The odds ratio (OR) was considered to evaluate the risk of exposure and a p value < 0.05 was considered significant, with a 95% confidence interval (95%CI) for all analyses.
Results

Demographic characteristics
The sample consisted of 265 current smokers, 335 exsmokers and 472 nonsmokers, totaling 1,072 patients. The demographic data are shown in Tables 1 and 2 . Table 1 , which compares CE smokers (current and exsmokers) with nonsmokers, shows that there was no significant difference regarding the age range between the groups. There were more male patients in the CE group when compared to the nonsmoker group, respectively: 72.7% and 30.3% (p < 0.000). Regarding the 8 comorbidities studied, a statistical difference was observed in only 4 of them, when the CE smokers were compared with the nonsmokers, respectively: coronary disease (12.7% vs 6.4%, p < 0.001), cerebrovascular accident (12.7 vs 6.4%, p < 0.001), diabetes mellitus (18.7% vs 24.8%, p < 0.019) and chronic obstructive pulmonary disease (17.7% vs 3.4%, p < 0.000). Considering the assessment scores of CE smokers and nonsmokers, a statistical significance was observed between the two groups for the ASA score as well as for the ACP score. In the group of CE smokers, there is a higher number of patients classified as ASA III and IV/V (19.5% and 3.8%) when compared with the nonsmokers (14.6% and 1.5%, p = 0.04 and 0.03, respectively). In this group there is also a higher number of patients at high risk by the ACP score (4%) when compared to the nonsmokers (1.5%, p = 0.24). The CE smokers were submitted to more emergency (6.3%) and major (40.3%) surgeries than the nonsmokers (3.4% and 13.3%, p = 0.04 and 0.00, respectively).
When the current smokers are compared with the exsmokers (Table 2 ), a statistical difference can be observed regarding age, as the ex-smokers' group presents a higher number of patients aged 60 to 70 years (33.4%) and older than 70 years (34.3%), when compared to the current smokers' group (28.7% and 17.4%, p = 0.25 and 0.00, respectively). Regarding sex, there is a minimal difference between the groups favoring the male sex in the group of ex-smokers (76.1%), compared to 68.5% in the current smokers' group (confidence interval: 0.46-0.99). Regarding the 8 comorbidities studied, a statistical difference was observed in only four of them, when comparing current and ex-smokers, respectively: coronary disease (9.1% vs 15.5%, p = 0.025), heart failure (9.1% vs 16.4%, p = 0.011), diabetes mellitus (11.7% vs 24.2%, p < 0.000) and systemic arterial hypertension (41.1% vs 57.6%, p = 0.000). Considering the risk scores, no significance was observed regarding the ASA score. However, the ex-smokers' group presented a higher number of patients at intermediate cardiac risk (26,3%) than the smokers' group (12.8%), with statistical significance (p < 0.000). There was a higher prevalence of patients with low cardiac risk in smokers' group (83.8%), when compared to the ex-smokers' group (69.2%), p < 0.000. There was no statistical difference between the groups regarding the high cardiac risk or type of surgery.
Postoperative events
The time of hospitalization (3-5 days) in the CE smokers' group (Table 3) was longer than that of the nonsmokers' group (11.8% vs 6.5%, p < 0.006) or more than 5 days (41.9% vs 26.7%, p < 0.000). The hospitalization time in the nonsmokers' group was less than 3 days, a more frequent period than the one observed in the CE smokers' group (66.7% vs 46.3%, p < 0.000). The combined cardiac events were more frequent in the CE smokers' group than in the nonsmokers' group, respectively: 8.8% and 3.8%, p = 0.002. The CE smokers presented a 2.44-fold higher chance of developing some postoperative cardiac event than the nonsmokers. In these two groups, nonfatal infarction and cardiac death were not significant. The CE smokers presented a 2.62-fold higher chance of death at 30 days than the nonsmokers (p = 0.024 and CI > 95%). The time of hospitalization, combine cardiac events, myocardial infarction, cardiac death and 30-day mortality did not present statistical significance when comparing current and ex-smokers (Table 4) .
Emergency surgery (odds ratio (OR) = 19.32), heart failure functional class ≥ II (OR=18.12) and left ventricular overload (OR=5.54) were independent variables associated with combined cardiac events in intermediate-risk surgeries (Table  5) . Regarding the 30-day mortality (Table 6) Emergency surgery (OR = 4.87), myocardial revascularization (OR = 4.01), ventricular extrasystoles (OR = 3.34), left ventricular overload (OR = 2.51) and age (OR = 1.07) were independent variables associated to postoperative combined cardiac events (Table 7) . Regarding the 30-day mortality (Table  8) , the independent variables were: left ventricular overload (OR = 4.29), current smokers (OR = 5.99), age (OR = 1.10) and laboratory alterations (OR = 10.25).
Discussion
Cardiovascular complications are frequently observed in current and ex-smokers submitted to intermediate and highrisk surgeries and even more in those individuals submitted to vascular surgeries. These data re corroborated by other authors 23, [26] [27] [28] [29] . The independent variables associated with cardiac events were: age, emergency surgery, heart failure functional class ≥ II (HF ≥ II), left ventricular overload (LVO), myocardial revascularization and ventricular extrasystoles; however, smoking was not independently associated. These findings have been documented in the literature 22, 26, 30, 31 .
Original Article
Arq Bras Cardiol 2010;94(5):587-594 However, in these studies, the heart failure variable presented a more severe clinical expression to associate to events, whereas the present study less severe forms already had a great impact, increasing the chance of cardiac events by 18-fold. The preoperative assessment guidelines 31, 32 recommend to consider the presence of heart failure as an important variable, regardless of clinical signs; however, one must not forget that decompensation and advanced functional class represent high-risk conditions for perioperative cardiac complications. The myocardial revascularization appeared as an independent variable, but in this case, its expression is that of a marker of coronary disease.
Sakuma et al Smoking as an independent risk factor
At the assessment of 30-day mortality, the following independent variables were found: age, emergency surgery, HF ≥ II, laboratory alterations, history of hepatopathy, surgeries due to neoplasia and habit of smoking. As it can be observed, the higher the number of systems affected in the preoperative period, the higher the probability of death. Many of the described variables (age, HF > II, LVO, laboratory alterations and emergency surgery) are associated with perioperative cardiovascular events 21, 31, [26] [27] [28] [29] , which are associated with mortality. The history of hepatopathy was associated with mortality probably due to the fact that it increases the chance of perioperative infection, sepsis 33 and acute renal failure 34 . The surgeries due to neoplasia were also independently associated with mortality, probably due to the patient's malnutrition condition and/or due to advanced disease. The current habit of smoking was associated with 30-day mortality in high-risk surgeries, increasing the chance of death by 5.99-fold (p=0.038). This information is very important, because this is a modifiable variable before an elective surgery, as well as the laboratory alterations.
When we analyzed the habit of smoking associated with cardiovascular events and 30-day mortality, we verified that few studies considered smoking as an independent varaible 8, 11 , as most of the studies reported this variable as one of the risk factors more often related to pulmonary events and less often related to cardiovascular ones 7, 8, 13 .
When we compared CE smokers and nonsmokers, of the 8 studied comorbidities only 4 presented an association with smoking, respectively: coronary disease (12.7% vs 6.4%, p < 0,001), cerebrovascular accident (12.7 vs 6.4%, p < 0.001), diabetes mellitus (18.7% vs x 24.8%, p < 0.019) and chronic obstructive pulmonary disease (17.7% vs 3.4%, p < 0.000), with exception of diabetes mellitus, which presented a higher incidence in the nonsmokers' group.
When we compared current and ex-smokers regarding the 8 studied comorbidities, a statistical difference was observed, respectively: coronary disease (9.1% vs 15.5%, p = 0.025), heart failure (9.1% vs 16.4%, p = 0.011), diabetes mellitus (11.7% vs 24.2%, p < 0.000) and systemic arterial hypertension (41.1% vs 57.6%, p = 0.000). It is known that tobacco is an important risk factor for atherosclerosis and thus, one must not disregard its role in perioperative cardiac complications. Tobacco affects myocardial oxygen offer and consumption during the perioperative period due to the increase in the coronary vascular resistance (vasoconstriction and increased platelet aggregation) and the high levels of carboxyhemoglobin 35 . Researchers have demonstrated an association between smoking and postoperative cardiac complications, but very often without much consistency 36, 37 .
A few studies have suggested that the discontinuation of the habit of smoking in the preoperative period can decrease the postoperative pulmonary complications 13, 38 ; however, the impact on mortality and postoperative cardiac events is not clear and it is not known exactly how long before the surgery the habit of smoking should be discontinued so that no complications occur.
The present study presents limitations when answering this question. The ex-smokers were at a higher age range and had a higher number of comorbidities (diabetes, hypertension, heart failure) when compared to smokers. These data were not considered an independent risk factor for 30-day mortality, although they presented more severe conditions (ASA III and IV and intermediate and high-risk ACP) and the patients presented more comorbidities than the current smokers. The fact that they had stopped smoking certainly contributed to decrease this severity in the postoperative period (protective effect), which was confirmed by the clinical compensation before the surgery and a more rigorous postoperative period. As for the smokers, we believe that the fact that they continued smoking in the postoperative period increased and aggravated the cardiovascular risk, potentiated by the age factor and by the surgical type (intermediate and high-risk), which caused these patients' decompensation and death. The discontinuation of the habit of smoking can normalize the levels of carbon monoxide in 8 hours, decrease the risk of infarction in 24 hours, improve the cardiorespiratory function in 14 to 90 days, decrease the coughing and normalize ciliary function in 1 to 9 months, decrease the risk of coronary disease by 50% in 1 year and decrease the risk of cerebrovascular accident by 50% in 5 years. Moreover, the risk of coronary disease is the same of that of the nonsmoker in 15 years 39 .
Conclusion
In the present study, age range, emergency surgery, heart failure functional class ≥ II (HF≥ II), left ventricular overload, myocardial revascularization and ventricular extrasystoles were independently associated with perioperative cardiovascular events. The habit of smoking was not observed as being
